全文获取类型
收费全文 | 1732篇 |
免费 | 97篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 18篇 |
儿科学 | 89篇 |
妇产科学 | 25篇 |
基础医学 | 238篇 |
口腔科学 | 204篇 |
临床医学 | 148篇 |
内科学 | 348篇 |
皮肤病学 | 33篇 |
神经病学 | 147篇 |
特种医学 | 104篇 |
外科学 | 162篇 |
综合类 | 16篇 |
预防医学 | 126篇 |
眼科学 | 41篇 |
药学 | 91篇 |
中国医学 | 13篇 |
肿瘤学 | 33篇 |
出版年
2023年 | 6篇 |
2022年 | 27篇 |
2021年 | 35篇 |
2020年 | 22篇 |
2019年 | 29篇 |
2018年 | 28篇 |
2017年 | 38篇 |
2016年 | 35篇 |
2015年 | 44篇 |
2014年 | 55篇 |
2013年 | 92篇 |
2012年 | 105篇 |
2011年 | 98篇 |
2010年 | 77篇 |
2009年 | 60篇 |
2008年 | 115篇 |
2007年 | 91篇 |
2006年 | 92篇 |
2005年 | 75篇 |
2004年 | 62篇 |
2003年 | 41篇 |
2002年 | 44篇 |
2001年 | 46篇 |
2000年 | 37篇 |
1999年 | 30篇 |
1998年 | 32篇 |
1997年 | 36篇 |
1996年 | 29篇 |
1995年 | 35篇 |
1994年 | 24篇 |
1993年 | 37篇 |
1992年 | 22篇 |
1991年 | 22篇 |
1990年 | 26篇 |
1989年 | 23篇 |
1988年 | 21篇 |
1987年 | 18篇 |
1986年 | 16篇 |
1985年 | 14篇 |
1984年 | 4篇 |
1983年 | 5篇 |
1982年 | 7篇 |
1981年 | 15篇 |
1980年 | 6篇 |
1978年 | 6篇 |
1977年 | 8篇 |
1976年 | 13篇 |
1975年 | 6篇 |
1972年 | 4篇 |
1966年 | 4篇 |
排序方式: 共有1836条查询结果,搜索用时 31 毫秒
1.
2.
3.
D Gröne† R Treudler† EM de Villiers‡ R Husak† CE Orfanos† ChC Zouboulis†§ 《Journal of the European Academy of Dermatology and Venereology》2006,20(2):202-205
Cidofovir is an acyclic nucleoside phosphonate with broad-spectrum activity against DNA viruses, including human papilloma virus (HPV). However, data on the efficacy of cidofovir in an immunosuppressive setting remain contradictory. We report for the first time on the promotion of the healing of recalcitrant warts in a patient with myelodysplastic syndrome with intravenous cidofovir treatment. 相似文献
4.
5.
6.
7.
M B Ferraz R M Ciconelli P M Araujo L M Oliveira E Atra 《The Journal of hand surgery》1992,17(6):1099-1103
Grip strength is one of the traditional outcome measures commonly used in rheumatoid arthritis trials. This study evaluated the degree of morning variation and the effect of elbow flexion in the assessment of grip strength in patients with rheumatoid arthritis. Grip strength was measured in 37 patients (1987 American Rheumatism Association criteria) at 8, 10, and 12 AM with a sphygmomanometer cuff folded on itself, taped permanently, and inflated to 20 mm Hg, with the elbow flexed at 90 degrees. At 10 AM grip strength was also measured with the elbow flexed at 30 and 130 degrees. Mean values for grip strength at 8, 10, and 12 AM were, respectively, 69, 79, and 83 mm Hg. Mean grip strength values with the elbow flexed at 30, 90, and 130 degrees were, respectively, 78, 79, and 75 mm Hg. There was a statistically significant correlation between grip strength and morning stiffness, grip strength and hand function, and grip strength and number of active joints. In rheumatoid arthritis trials, grip strength should be assessed at the same time of the day. Elbow flexion does not play a role in grip strength measurement. 相似文献
8.
Stressors in ICU: patients’ evaluation 总被引:3,自引:0,他引:3
M. A. F. P. Novaes A. Aronovich M. B. Ferraz E. Knobel 《Intensive care medicine》1997,23(12):1282-1285
Objective: To study the physical and psychological stressors in the intensive care unit (ICU) and to correlate stressors with different
demographic variables. Design: Cross-sectional analytical survey. Setting: Intensive care unit of a private hospital. Patients and participants: 50 randomly selected ICU patients during the first week of their ICU stay. Measurements and results: The Intensive Care Unit Environmental Stressor Scale was administered to 50 patients. Pain and the impossibility of sleeping
due to noise and having tubes in the nose and mouth were considered the most important physical stressors. Loss of self control
and lack of understanding about the attitudes and procedures were the main psychological stressors. Conclusions: Interventions should be aimed at relieving the patient's pain and at controlling the level of noise to make sleep possible.
From the psychological standpoint, the independence of the patient should be encouraged, thus stimulating the recovery of
self-control. The team should also inform the patient about the procedures which will be carried out.
Received: 1 April 1997 Accepted: 24 September 1997 相似文献
9.
The receptor tyrosine kinase (RTK) Ret is activated by the formation of a complex consisting of ligands such as glial cell line-derived neurotrophic factor (GDNF) and glycerophosphatidylinositol-anchored coreceptors termed GFRalphas. During activation, Ret translocates into lipid rafts, which is critical for functional responses to GDNF. We found that Ret was rapidly ubiquitinated and degraded in sympathetic neurons when activated with GDNF, but, unlike other RTKs that are trafficked to lysosomes for degradation, Ret was degraded predominantly by the proteasome. After GDNF stimulation, the majority of ubiquitinated Ret was located outside of lipid rafts and Ret was lost predominantly from nonraft membrane domains. Consistent with the predominance of Ret degradation outside of rafts, disruption of lipid rafts in neurons did not alter either the GDNF-dependent ubiquitination or degradation of Ret. GDNF-mediated survival of sympathetic neurons was inhibited by lipid raft depletion, and this inhibitory effect of raft disruption on GDNF-mediated survival was reversed if Ret degradation was blocked via proteasome inhibition. Therefore, lipid rafts sequester Ret away from the degradation machinery located in nonraft membrane domains, such as Cbl family E3 ligases, thereby sustaining Ret signaling. 相似文献
10.
Claudio R Cernea Alberto R Ferraz Inês V de Castro Miriam N Sotto Angela F Logullo Carlos E Bacchi André S Potenza 《Otolaryngology--head and neck surgery》2006,134(3):471-475
BACKGROUND: Some skin carcinomas may be very aggressive. Increased expression of the protein p53 has been associated with tumor aggressiveness. In this study, p53 expression was evaluated in basal cell carcinomas (BCC) and squamous cell carcinomas (SCC) with skull base invasion, and was compared to tumors with good outcome. STUDY DESIGN AND SETTING: Expression of p53 was immunohistochemically analyzed and it was reported as present or absent in 24 BCC and 11 SCC with skull base invasion. Control group (good outcome) included 23 BCC and 10 SCC. RESULTS: Expression of p53 was noted in 70.83% of BCC with skull base invasion, compared to 43.48% in the control group (P = 0.058). Regarding SCC, p53 positivity was noted in only 9.09% of SCC with skull base invasion, compared to 40.00% in the control group (P = 0.149). CONCLUSIONS: In this study, p53 expression was more common among BCC with skull base invasion, compared to controls with good outcome, and the difference was considered marginally significant. This proportion was reversed in SCC, but the difference was not statistically significant. EBM rating: B-3b. 相似文献